Mode
Text Size
Log in / Sign up
N/A N=166 Treatment

Electrical Stimulation for the Treatment of Back Pain Using Peripheral Nerve Stimulation (PNS)

Back Pain · Low Back Pain

Enrolled (actual)
166
Serious AEs
4.0%
Results posted
Aug 2022
Primary outcome: Primary: Number of Subjects That Experienced ≥30% Reduction in Average Low Back Pain Intensity — 58 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
SPRINT Peripheral Nerve Stimulation (PNS) System (Device)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
SPR Therapeutics, Inc.
Primary completion
May 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Subjects That Experienced ≥30% Reduction in Average Low Back Pain Intensity
58
PRIMARY
Number of Subjects That Experienced at Least One Study-Related Adverse Event
49
SECONDARY
Worst Pain Intensity
7.7; 4.5
SECONDARY
Oswestry Disability Index (ODI)
39.1; 23.6
SECONDARY
Mean Change in Health-Related Quality of Life
13.2; 26.6; 12.2; 12.8; 7.2; 18.0
SECONDARY
Beck Depression Inventory (BDI-II)
8.9; 5.2
SECONDARY
Patient Global Impression of Change (PGIC) Survey
12; 39; 23; 8; 0; 1
SECONDARY
Pain Interference
5.7; 2.8

Summary

The purpose of this study is to evaluate the effectiveness of electrical stimulation (low levels of electricity) on low back pain. This study involves the SPRINT Peripheral Nerve Stimulation (PNS) system. The System delivers mild electrical stimulation to the nerves in the low back. The System includes up to four small wires (called "Leads") that are placed through the skin into the muscles in the low back. The wires attach to device(s) worn on the body that deliver stimulation (called Stimulators).

Eligibility Criteria

Key Inclusion Criteria

  • At least 21 years of age
  • Chronic low back pain

Key Exclusion Criteria

  • Infection on or around the low back
  • Conditions with increased risk of infection (e.g., valvular heart disease, compromised immune system, history of recurrent skin infections)
  • Implanted electronic device
  • Body Mass Index (BMI) > 40
  • Pregnant
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03179202). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search